Alprostadil (Caverject/MUSE) Cost in California 2026

What Does Alprostadil Cost in California Without Insurance?

The average cash-pay price for brand alprostadil in California runs about $600 per month in 2026, whether you fill Caverject (the intracavernosal injection) or MUSE (the urethral suppository). That figure comes from retail pharmacy pricing across major California chains including CVS, Walgreens, and Rite Aid. The per-unit cost matters more for on-demand medications like this one because most men do not use 30 doses in a month.

A single Caverject Impulse 20 mcg dual-chamber syringe retails between $85 and $110 at California pharmacies in 2026. A box of 6 MUSE 1000 mcg suppositories lists near $350 to $400 at the same chains. GoodRx and similar discount platforms can pull the per-syringe Caverject price down to roughly $70 to $90 at select California locations, depending on which pharmacy accepts the coupon on a given day. [1]

Alprostadil works by binding to prostaglandin EP2 and EP3 receptors in cavernosal smooth muscle, producing cyclic AMP-mediated relaxation and penile tumescence. [2] The landmark Linet et al. trial published in the New England Journal of Medicine (N=296 men with erectile dysfunction) reported that intracavernosal alprostadil produced satisfactory erections in 94% of in-clinic attempts and that 87% of at-home injection attempts were successful, compared with 15% for placebo (P<0.001). [3] That efficacy profile is why clinicians continue to prescribe it despite the price.

Generic intracavernosal alprostadil (manufactured by companies including Sandoz and Perrigo) carries a lower list price than Caverject. A single-dose generic vial can run $50 to $80 at California pharmacies, though availability varies by region. Calling ahead to confirm stock is practical advice, not a formality.

The table below summarizes 2026 California cash-pay pricing across dose forms:

| Product | Strength | Units | Approx. Cash Price (CA, 2026) | |---|---|---|---| | Caverject Impulse (Pfizer) | 20 mcg | 1 syringe | $85, $110 | | Caverject Impulse (Pfizer) | 40 mcg | 1 syringe | $100, $125 | | Generic alprostadil injection | 20 mcg | 1 vial | $50, $80 | | MUSE (Vivus) | 500 mcg | 6 suppositories | $290, $340 | | MUSE (Vivus) | 1000 mcg | 6 suppositories | $350, $400 | | Compounded alprostadil (503A) | Variable | Variable | Varies by pharmacy |

Does Medi-Cal Cover Alprostadil in California?

Medi-Cal (California's Medicaid program) covers alprostadil for erectile dysfunction, but prior authorization (PA) is required. [4] The PA criteria align with a diagnosis of organic or refractory ED documented by a prescribing physician or urologist. Self-reported psychogenic ED alone does not typically satisfy the authorization standard without additional clinical documentation.

Once PA is approved, the Medi-Cal formulary covers both the intracavernosal injection form and, in most managed care plans, MUSE suppositories. The patient copayment for most Medi-Cal beneficiaries is $1 to $3 per prescription fill. [5] That is a dramatic reduction from the $600 monthly cash price.

The American Urological Association (AUA) 2018 guideline on erectile dysfunction states: "Intracavernosal vasoactive drug therapy (e.g., alprostadil) should be offered to patients who do not respond to oral PDE5 inhibitors or who cannot take them." [6] That language strengthens a PA request when a patient has already failed sildenafil or tadalafil.

To initiate PA for Medi-Cal coverage, the prescriber must submit:

• A confirmed diagnosis of erectile dysfunction (ICD-10 N52.x)
• Documentation of PDE5 inhibitor failure or contraindication (for example, concomitant nitrate use)
• The proposed dose form and anticipated frequency

Medi-Cal managed care plans (including LA Care, Inland Empire Health Plan, and Anthem Blue Cross Medi-Cal) may have their own PA forms that differ from fee-for-service Medi-Cal. Checking with the specific plan before submitting avoids delays.

Which Commercial Insurance Plans Cover Alprostadil in California?

Most California commercial plans place alprostadil on Tier 3 or Tier 4 of their formulary. That means a 30-day supply copay typically runs $60 to $150 for patients with standard cost-sharing, though plans with high deductibles may require patients to pay the full negotiated rate until the deductible is met. [7]

Blue Shield of California, Anthem Blue Cross, and Kaiser Permanente (Northern and Southern California) all list alprostadil as a covered benefit under their 2026 formularies, subject to PA for the intracavernosal form. MUSE suppositories receive coverage under some but not all plans; verification before prescribing saves the patient a surprise bill.

The California Department of Managed Health Care (DMHC) enforces mental health and medical parity rules. Because erectile dysfunction has recognized physiological causes, a plan denial of alprostadil coverage for organic ED may be appealable under California's Independent Medical Review (IMR) process. [8] Patients who receive denials can file an IMR request at no cost through DMHC within 180 days of the denial notice.

Covered California marketplace plans follow the same general Tier 3 to Tier 4 pattern. Patients purchasing silver or gold plans through the exchange typically see lower cost-sharing than those on bronze-tier coverage.

Is Compounded Alprostadil Legal in California?

Compounded alprostadil is legal in California when prepared by a pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act and licensed by the California State Board of Pharmacy. [9] The FDA defines 503A pharmacies as traditional compounding pharmacies that prepare medications based on individual patient prescriptions. They operate under state board oversight rather than the FDA manufacturing standards that apply to 503B outsourcing facilities.

A licensed 503A pharmacy in California can compound alprostadil in several formulations not commercially available, including trimix (alprostadil combined with papaverine and phentolamine) and bimix (alprostadil with papaverine). These combination formulas are popular because lower doses of each component may produce equivalent or superior results compared to alprostadil alone, potentially with a lower local side-effect burden. [10]

The California State Board of Pharmacy maintains a license-verification database. Before filling a compounded alprostadil prescription, patients should confirm the pharmacy holds an active California compounding pharmacy license and that the prescribing physician holds a valid California medical license.

Cost is the main driver of interest in compounded alprostadil. Depending on the compounding pharmacy and the specific formulation, compounded alprostadil or trimix can be substantially less expensive than brand Caverject, with some pharmacies offering formulations in the range of $80 to $180 for a multi-dose vial. The wide range reflects differences in formulation concentration, vial size, and pharmacy overhead. Some telehealth-affiliated 503A pharmacies offer pricing that makes alprostadil accessible at a fraction of the brand retail price.

One practical caution: compounded drugs do not carry FDA approval for safety, efficacy, or manufacturing consistency in the same way that brand or FDA-approved generic drugs do. [11] The prescribing physician and the compounding pharmacist share responsibility for clinical quality and sterility, particularly for intracavernosal preparations where sterility is non-negotiable.

Can You Get Alprostadil via Telehealth in California?

Yes. California permits telehealth prescribing of alprostadil. [12] A licensed California physician, nurse practitioner, or physician assistant can evaluate a patient via synchronous video visit, confirm an erectile dysfunction diagnosis, and transmit a prescription electronically to a California pharmacy without an in-person appointment. Post-pandemic telehealth rules that relaxed prescribing requirements for non-controlled substances have been codified in California law, making this a durable option rather than a temporary measure.

Most telehealth platforms serving California ED patients require the patient to complete a medical history intake, provide a current medication list, and participate in a live video or asynchronous photo-based evaluation. Because alprostadil is not a controlled substance, it does not require the same prescribing restrictions that apply to, for example, testosterone or schedule II medications.

Practical steps for a California telehealth alprostadil visit:

1. Complete the platform's online medical intake form, including past PDE5 inhibitor use and any cardiovascular history.
2. Attend the synchronous video visit or submit asynchronous intake for clinician review.
3. The clinician determines the appropriate dose form (injection vs. suppository) and starting dose.
4. The prescription routes electronically to either a retail pharmacy or a licensed 503A compounding pharmacy, depending on the treatment plan.
5. An injection training session (in-person or via video) is strongly recommended before first use, as improper technique raises the risk of penile bruising, priapism, or fibrosis. [13]

The AUA recommends that the first injection dose be administered in a clinical setting to monitor for hypotension and to titrate to the correct dose for that patient. Telehealth does not eliminate this recommendation; some platforms address it by directing California patients to a local urology office for the first dose.

How Does the Pfizer Savings Card Work in California?

Pfizer offers a Caverject savings program for commercially insured patients. As of 2026, eligible patients pay no more than a capped copay per fill (the specific cap is subject to change; check the Caverject savings card enrollment page directly). California patients who have private insurance (not Medi-Cal, Medicare, or any other federal program) can enroll online or through their prescribing physician's office. [14]

The savings card does not apply to Medi-Cal, Medicare Part D, or any other government-funded insurance. This is a federal restriction, not a California-specific one. Patients on federal programs need to pursue the PA route described above or consider compounded alternatives.

VIVUS, the maker of MUSE, does not currently offer a broad consumer savings card comparable to Pfizer's. Patient assistance programs for low-income uninsured patients may be available through NeedyMeds.org or the manufacturer's own patient assistance program; eligibility varies by income and insurance status.

Generic alprostadil manufacturers do not uniformly offer savings cards, but GoodRx coupons at select California pharmacies can reduce the cost of generic intracavernosal alprostadil to roughly $50 to $75 per vial. [15]

What Are the Clinical Basics California Prescribers Evaluate?

Alprostadil received FDA approval for erectile dysfunction in 1995 (Caverject injection, NDA 019941) and in 1997 (MUSE intraurethral suppository, NDA 020365). [16] The mechanism is direct stimulation of adenylate cyclase in cavernosal smooth muscle via EP receptor agonism, increasing intracellular cyclic AMP and producing smooth muscle relaxation independent of nitric oxide pathways. This is why alprostadil works in patients who fail PDE5 inhibitors, since PDE5 inhibitors require intact nitric oxide signaling.

Standard starting doses for intracavernosal alprostadil are 2.5 mcg for neurogenic ED and 5 mcg for vasculogenic or mixed ED, titrated upward in the office until a satisfactory erection of no more than 60 minutes is achieved. [17] The maximum recommended single dose is 40 mcg. Patients should not use alprostadil more than three times per week and not on consecutive days.

For MUSE, the starting dose is 125 mcg or 250 mcg inserted intraurethrally, with titration up to 1000 mcg. MUSE generally produces a less rigid erection than intracavernosal injection and is preferred by patients who cannot self-inject or find injection intolerable. [18]

Absolute contraindications include known hypersensitivity to alprostadil, conditions predisposing to priapism (sickle-cell disease, multiple myeloma, leukemia), and anatomical penile deformities that could worsen with injection. [19] Men with MUSE must also use a condom if a pregnant partner is present, as absorbed prostaglandin E1 may affect fetal/uterine tissue.

The most common adverse effects reported in the Linet et al. NEJM trial were penile pain (occurring in 37% of patients at some point during treatment) and prolonged erection requiring medical attention in 1% of injection attempts. [3] Patients should be counseled to seek emergency care for any erection lasting longer than 4 hours, as untreated priapism causes permanent cavernosal fibrosis. [20]

How to Reduce Alprostadil Costs in California: A Practical Summary

Several paths exist for California patients aiming to lower their out-of-pocket cost. None requires compromising clinical quality.

Medi-Cal with prior authorization. For qualifying low-income California residents, Medi-Cal PA approval reduces cost to a nominal copay. The prescribing clinician carries most of the administrative burden here.

Commercial insurance PA plus Pfizer savings card. Patients with private insurance who receive a PA approval and enroll in the Pfizer savings card may reach a monthly cost well below the $600 cash price. Stacking both strategies is permitted.

Generic intracavernosal alprostadil. FDA-approved generic formulations cost 20% to 35% less than brand Caverject at California retail pharmacies. [21] Clinical equivalence is established; the generic contains the same active moiety at the same dose.

Licensed 503A compounding pharmacy. For patients who have failed standard alprostadil alone or who want trimix, a compounding pharmacy can produce a formulation at lower per-dose cost. Confirm California State Board of Pharmacy licensure before purchasing.

GoodRx or similar discount platforms. No insurance required. The discount applies at point of sale and reduces the cash price at participating California pharmacies. The GoodRx price is not always lower than insurance, so comparison shopping before each fill is worthwhile.

Patient assistance programs. Pfizer's RxPathways and NeedyMeds.org list programs for uninsured or underinsured patients. Income thresholds apply. [22]